Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic diseases marked by too low levels of specific cellular proteins. To boost those proteins, they’ve created experimental versions of a genetic “tail” that attaches to so-called mRNA molecules that churn out the proteins.

Artificial Intelligence (AI) is poised to transform healthcare, but its successful integration into healthcare requires careful consideration of regulatory frameworks, governance structures, data equity, and privacy protections. To help their academic community coalesce around this challenge, a team comprised of researchers from Lehigh University, Massachusetts General Hospital/Harvard Medical School, and Northwestern University's Feinberg School of Medicine are gathering researchers, clinicians, and industry experts in this space as part of the 2025 Spring Symposium Series sponsored by the Association for the Advancement of Artificial Intelligence (AAAI.) The team's "Leveraging AI to Revolutionize Healthcare" symposium will be a key portion of the 2025 AAAI Spring Symposium Series, set for Monday, March 31 through Wednesday, April 2, 2025, at the San Francisco Airport Marriott Waterfront in Burlingame, California.

Five multidisciplinary teams received seed grants to develop community-informed solutions for better health.

A state-run pilot program aimed at helping North Carolina Medicaid recipients address their health-related social needs, such as food insecurity and housing instability, led to less spending over time compared to what would have been expected otherwise.